ReviewInflammopharmacology2026

Nanomedicine targeting neuroinflammatory pathways in Alzheimer's disease: a new frontier in inflammopharmacology.

Sumit Kaushik et al.PubMed ↗Publisher ↗

No numbers read from the abstract.